γ6-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancerSCIENCE ADVANCESIF12.52023-05-0523OAAI
4-1BB AND OPTIMIZED CD28 CO-STIMULATION ENHANCES FUNCTION OF HUMAN MONO- AND BI-SPECIFIC THIRD-GENERATION CAR T CELLSJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-11-100OA
4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cellsJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-10-2765OAAI
High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer (vol 23, 40, 2021)BREAST CANCER RESEARCHIF5.62021-04-220OAAI
High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancerBREAST CANCER RESEARCHIF5.62021-03-2521OAAI
Insight into next-generation CAR therapeutics designing CAR T cells to improve clinical outcomesJOURNAL OF CLINICAL INVESTIGATIONIF13.62021-01-1959OA
Photodynamic Modulation of Type 1 Interferon Pathway on Melanoma Cells Promotes Dendritic Cell ActivationFRONTIERS IN IMMUNOLOGYIF5.92019-11-0836OAAI
Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivityPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12019-11-0782OAAI
CAR-T Engineering: Optimizing Signal Transduction and Effector MechanismsBIODRUGSIF6.92019-09-2429PREAI
γδ CAR T-cell therapy significantly mitigates bone metastatic castrate-resistant prostate cancerCANCER RESEARCHIF16.62019-07-010PRE
TLR3 Activation of Intratumoral CD103+ Dendritic Cells Modifies the Tumor Infiltrate Conferring Anti-tumor ImmunityFRONTIERS IN IMMUNOLOGYIF5.92019-03-2025OAAI
In Vivo Visualizing the IFN-β Response Required for Tumor Growth Control in a Therapeutic Model of Polyadenylic-Polyuridylic Acid AdministrationJOURNAL OF IMMUNOLOGYIF3.42016-03-1513OAAI